These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD. Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [Abstract] [Full Text] [Related]
26. [Interaction of adenosine with leukocytes and thrombocytes]. Becker BF, Zahler S, Seligmann C, Kupatt C, Habazettl H. Z Kardiol; 1996 Mar; 85 Suppl 6():161-70. PubMed ID: 9064961 [Abstract] [Full Text] [Related]
27. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Sawmiller DR, Henning RJ, Cuevas J, Dehaven WI, Vesely DL. Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194 [Abstract] [Full Text] [Related]
28. Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation. Edlund A, Sollevi A. Acta Physiol Scand; 1995 Nov; 155(3):303-11. PubMed ID: 8619329 [Abstract] [Full Text] [Related]
30. Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Wu SN, Linden J, Visentin S, Boykin M, Belardinelli L. Circ Res; 1989 Oct; 65(4):1066-77. PubMed ID: 2551526 [Abstract] [Full Text] [Related]
32. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG. Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341 [Abstract] [Full Text] [Related]
33. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig. Haynes JM, Alexander SP, Hill SJ. Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342 [Abstract] [Full Text] [Related]
35. Adenosine A1-receptor occupancy predicts A1-receptor antagonist effects of N-0861. Yasuda SU, Nagashima S, Douyon E, Benton RE, Woosley RL, Barbey JT. Clin Pharmacol Ther; 1998 Nov; 64(5):536-41. PubMed ID: 9834045 [Abstract] [Full Text] [Related]
36. PACPX--a substituted xanthine--antagonizes both the A1 and A2 subclasses of the P1-purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not. Burnstock G, Hoyle CH. Br J Pharmacol; 1985 May; 85(1):291-6. PubMed ID: 2992653 [Abstract] [Full Text] [Related]